Published in Cancer Weekly, December 20th, 2005
Cytogen is now reporting a net loss of $7.1 million, or $0.40 per basic and diluted share, in the third quarter of 2005, compared to a net loss of $7.8 million, or $0.44 per basic and diluted share,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.